NCT07507747 Testing an Adaptive Intervention for Peer-Supported Mobile Health for Primary Care Veterans With Psychological Distress
| NCT ID | NCT07507747 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Office of Research and Development |
| Condition | Psychological Distress |
| Study Type | INTERVENTIONAL |
| Enrollment | 384 participants |
| Start Date | 2026-09-27 |
| Primary Completion | 2029-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 384 participants in total. It began in 2026-09-27 with a primary completion date of 2029-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Many Veterans experience psychological distress including depression, post-traumatic stress disorder (PTSD), anxiety and problems with sleep and anger. Services to address these problems need to be easy for Veterans to access. VA mobile health applications (mHealth apps) that teach skills to manage psychological distress are widely available. However, Veterans rarely use these apps enough to experience health benefits. Peer specialists are VA employees who are trained to use their lived experiences in mental health recovery to help other Veterans. Peers can provide support and accountability to Veterans as they use mHealth apps. Peers working in VA primary care settings are easily accessible to Veterans who receive VA services. This study aims to improve the health of Veterans by testing the effectiveness of peer-supported mHealth in reducing psychological distress. It will also test how much peer support Veterans need to improve their health with using mHealth apps.
Eligibility Criteria
Inclusion Criteria: * Veteran enrolled in primary care at one of 3 VA facilities (Philadelphia, PA; Ann Arbor, MI; and Bedford, MA) * clinically significant psychological distress on at least one DASS-21 subscale (Depression =\> 10, Anxiety =\> 8, Stress =\> 13) Exclusion Criteria: * symptoms that may preclude active engagement in the intervention such as gross cognitive impairment or current symptoms of mania or psychosis * suicide risk as measured by the P4 Suicide Assessment * plan to engage in psychotherapy during the intervention period * started or changed the dose of a psychotropic medication in the last two months * voice a preference to be directly referred to mental health specialty care
Contact & Investigator
Kyle Possemato, PhD
PRINCIPAL INVESTIGATOR
Syracuse VA Medical Center, Syracuse, NY
Frequently Asked Questions
Who can join the NCT07507747 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Psychological Distress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07507747 currently recruiting?
Yes, NCT07507747 is actively recruiting participants. Contact the research team at kyle.possemato@va.gov for enrollment information.
Where is the NCT07507747 trial being conducted?
This trial is being conducted at Palo Alto, United States, Bedford, United States, Ann Arbor, United States, Syracuse, United States and 1 additional location.
Who is sponsoring the NCT07507747 clinical trial?
NCT07507747 is sponsored by VA Office of Research and Development. The principal investigator is Kyle Possemato, PhD at Syracuse VA Medical Center, Syracuse, NY. The trial plans to enroll 384 participants.